Lixivaptan + Placebo
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Euvolemic Hyponatremia
Conditions
Euvolemic Hyponatremia
Trial Timeline
Jun 1, 2009 → —
NCT ID
NCT00876798About Lixivaptan + Placebo
Lixivaptan + Placebo is a phase 3 stage product being developed by Biogen for Euvolemic Hyponatremia. The current trial status is completed. This product is registered under clinical trial identifier NCT00876798. Target conditions include Euvolemic Hyponatremia.
Hype Score Breakdown
Clinical
17
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00876798 | Phase 3 | Completed |
| NCT00660959 | Phase 3 | Completed |
| NCT00578695 | Phase 3 | Completed |